Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report

Comprehensive molecular analysis based on somatic copy number alterations in intramucosal colorectal neoplasias and early invasive colorectal cancers

Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk

YdjC chitooligosaccharide deacetylase homolog induces keratin reorganization in lung cancer cells: involvement of interaction between YDJC and CDC16

Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers

Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer

Carbon ion radiotherapy for inoperable pediatric osteosarcoma

Combination of two anti-tubulin agents, eribulin and paclitaxel, enhances anti-tumor effects on triple-negative breast cancer through mesenchymal-epithelial transition

Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma

Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST

Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma

Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies

Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma

Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas

A targeted transforming growth factor-beta (TGF-β) blocker, TTB, inhibits tumor growth and metastasis

Association of increased primary breast tumor AGR2 with decreased disease-specific survival

Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes

SB202190 inhibits endothelial cell apoptosis via induction of autophagy and heme oxygenase-1

Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma

Gene expression profiling in prognosis of distant recurrence in HR-positive and HER2-negative breast cancer patients

RPGR protein complex regulates proteasome activity and mediates store-operated calcium entry

DGC-specific RHOA mutations maintained cancer cell survival and promoted cell migration via ROCK inactivation

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer

MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells

Chloride intracellular channel 1 as a switch among tumor behaviors in human esophageal squamous cell carcinoma

miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation

Cytokeratin 8/18 protects breast cancer cell lines from TRAIL-induced apoptosis

The effects of restricted glycolysis on stem-cell like characteristics of breast cancer cells

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau